Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.
Ontology highlight
ABSTRACT: Mucopolysaccharidoses (MPSs) are multiorgan devastating diseases for which hematopoietic cell transplantation (HCT) and, to a lesser extent, enzyme replacement therapy have substantially altered the course of the disease. Furthermore, they have resulted in increased overall survival, especially for Hurler disease (MPS-1). However, despite the identification of clinical predictors and harmonized transplantation protocols, disease progression still poses a significant burden to patients, although at a slower pace. To design better therapies, we need to understand why and where current therapies fail. In this review, we discuss important aspects of the underlying disease and the disease progression. We note that the majority of progressive symptoms that occur in "hard-to-treat" tissues are ac
SUBMITTER: van den Broek BTA
PROVIDER: S-EPMC7322951 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA